Superparamagnetic iron oxide and drug complex-embedded acoustic droplets for ultrasound targeted theranosis

Biomaterials

Volumn 34, Issue 7, 2013, Pages 1852-1861

  Wang, Chung Hsin ^a   Kang, Shih Tsung ^a   Yeh, Chih Kuang ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Acoustic droplet vaporization; Doxorubicin loaded; Focused ultrasound; Magnetic resonance imaging; Magnetism assisted ultrasound targeting image; Superparamagnetic iron oxide loaded

Indexed keywords

ACOUSTIC DROPLET VAPORIZATION; DOXORUBICIN-LOADED; FOCUSED ULTRASOUND; MAGNETISM-ASSISTED ULTRASOUND TARGETING IMAGE; SUPERPARAMAGNETICS;

IRON OXIDES; MAGNETIC PROPERTIES; MAGNETIC RESONANCE IMAGING; NANOMAGNETICS; SUPERPARAMAGNETISM; TUMORS; ULTRASONICS; VAPORS;

DROPS;

DOXORUBICIN; FLUOROCARBON; LIPID; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; RECEPTOR ANTIBODY; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 ANTIBODY;

ACOUSTIC DROPLET VAPORIZATION; ARTICLE; CELL DESTRUCTION; CONJUGATION; DRUG DELIVERY SYSTEM; ENCAPSULATION; GLIOMA CELL; HYSTERESIS; MAGNETISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ULTRASOUND; VAPORIZATION;

ACOUSTICS; ANIMALS; CELL LINE, TUMOR; FERRIC COMPOUNDS; MAGNETICS; NEOPLASMS; RATS; ULTRASONICS;

EID: 84871034471     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.037     Document Type: Article

References (41)

1. Ferrara K.W., Pollard R., Borden M.A. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007, 9:415-447.
2. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliver Rev 2008, 60:1193-1208.
3. Sokka S.D., King R., Hynynen K. MRI-guided gas bubble enhanced ultrasound heating in in vivo rabbit thigh. Phys Med Biol 2003, 48:223-241.
4. Luo W., Zhou X., Tian X., Ren X., Zheng M., Gu K., et al. Enhancement of ultrasound contrast agent in high-intensity focused ultrasound ablation. Adv Ther 2006, 23:861-868.
5. Ting C.Y., Fan C.H., Liu H.L., Huang C.Y., Hsieh H.Y., Yen T.C., et al. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 2012, 33:704-712.
6. Hynynen K., McDannold N., Vykhodtseva N., Raymond S., Weissleder R., Jolesz F.A., et al. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg 2006, 105:445-454.
7. Liu H.L., Hua M.Y., Yang H.W., Huang C.Y., Chu P.C., Wu J.S., et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A 2010, 107:15205-15210.
8. Hynynen K., McDannold N., Vykhodtseva N., Jolesz F.A. Non-invasive opening of BBB by focused ultrasound. Acta Neurochir Suppl 2003, 86:555-558.
9. Klibanov A.L. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006, 41:354-362.
10. Borden M.A., Longo M.L. Dissolution behavior of lipid monolayer-coated, air-filled microbubbles: effect of lipid hydrophobic chain length. Langmuir 2002, 18:9225-9233.
11. Ferrara K.W. Driving delivery vehicles with ultrasound. Adv Drug Deliver Rev 2008, 60:1097-1102.
12. Kripfgans O.D., Fowlkes J.B., Miller D.L., Eldevik O.P., Carson P.L. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 2000, 26:1177-1189.
13. Kawabata K., Sugita N., Yoshikawa H., Azuma T., Umemura S. Nanoparticles with multiple perfluorocarbons for controllable ultrasonically induced phase shifting. Jpn J Appl Phys 2005, 44:4548-4552.
14. Fabiilli M.L., Haworth K.J., Fakhri N.H., Kripfgans O.D., Carson P.L., Fowlkes J.B. The role of inertial cavitation in acoustic droplet vaporization. IEEE Trans Ultrason Ferroelectr Freq Control 2009, 56:1006-1017.
15. Zhang M., Fabiilli M.L., Haworth K.J., Fowlkes J.B., Kripfgans O.D., Roberts W.W., et al. Initial investigation of acoustic droplet vaporization for occlusion in canine kidney. Ultrasound Med Biol 2010, 36:1691-1703.
16. Kripfgans O.D., Fowlkes J.B., Woydt M., Eldevik O.P., Carson P.L. In vivo droplet vaporization for occlusion therapy and phase aberration correction. IEEE Trans Ultrason Ferroelectr Freq Control 2002, 49:726-738.
17. Rapoport N.Y., Kennedy A.M., Shea J.E., Scaife C.L., Nam K.H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009, 138:268-276.
18. Fabiilli M.L., Haworth K.J., Sebastian I.E., Kripfgans O.D., Carson P.L., Fowlkes J.B. Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion. Ultrasound Med Biol 2010, 36:1364-1375.
19. Wang C.H., Kang S.T., Lee Y.H., Luo Y.L., Huang Y.F., Yeh C.K. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 2012, 33:1939-1947.
20. Feshitan J.A., Vlachos F., Sirsi S.R., Konofagou E.E., Borden M.A. Theranostic Gd(III)-lipid microbubbles for MRI-guided focused ultrasound surgery. Biomaterials 2012, 33:247-255.
21. Holzbach T., Vlaskou D., Neshkova I., Konerding M.A., Wortler K., Mykhaylyk O., et al. Non-viral VEGF(165) gene therapy-magnetofection of acoustically active magnetic lipospheres ('magnetobubbles') increases tissue survival in an oversized skin flap model. J Cell Mol Med 2010, 14:587-599.
22. Chow A.M., Chan K.W., Cheung J.S., Wu E.X. Enhancement of gas-filled microbubble R2* by iron oxide nanoparticles for MRI. Magn Reson Med 2010, 63:224-229.
23. Yang F., Li Y., Chen Z., Zhang Y., Wu J., Gu N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 2009, 30:3882-3890.
24. Liu Z., Lammers T., Ehling J., Fokong S., Bornemann J., Kiessling F., et al. Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 2011, 32:6155-6163.
25. Xu B., Dou H., Tao K., Sun K., Ding J., Shi W., et al. Two-in-one" fabrication of Fe3O4/MePEG-PLA composite nanocapsules as a potential ultrasonic/MRI dual contrast agent. Langmuir 2011, 27:12134-12142.
26. Gorelikov I., Martin A.L., Seo M., Matsuura N. Silica-coated quantum dots for optical evaluation of perfluorocarbon droplet interactions with cells. Langmuir 2011, 27:15024-15033.
27. Mandal S.K., Lequeux N., Rotenberg B., Tramier M., Fattaccioli J., Bibette J., et al. Encapsulation of magnetic and fluorescent nanoparticles in emulsion droplets. Langmuir 2005, 21:4175-4179.
28. Beaune G., Dubertret B., Clement O., Vayssettes C., Cabuil V., Menager C. Giant vesicles containing magnetic nanoparticles and quantum dots: feasibility and tracking by fiber confocal fluorescence microscopy. Angew Chem Int Ed Engl 2007, 46:5421-5424.
29. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285:1182-1186.
30. Drake C.J., LaRue A., Ferrara N., Little C.D. VEGF regulates cell behavior during vasculogenesis. Dev Biol 2000, 224:178-188.
31. Plate K.H., Breier G., Millauer B., Ullrich A., Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993, 53:5822-5827.
32. Backer M.V., Aloise R., Przekop K., Stoletov K., Backer J.M. Molecular vehicles for targeted drug delivery. Bioconjug Chem 2002, 13:462-467.
33. Das A., Soehnlen E., Woods S., Hegde R., Henry A., Gericke A., et al. VEGFR-2 targeted cellular delivery of doxorubicin by gold nanoparticles for potential antiangiogenic therapy. J Nanopart Res 2011, 13:6283-6290.
34. van Vlerken L.E., Amiji M.M. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv 2006, 3:205-216.
35. Wicki A., Rochlitz C., Orleth A., Ritschard R., Albrecht I., Herrmann R., et al. Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth. Clin Cancer Res 2012, 18:454-464.
36. Kang S.T., Yeh C.K. Intracellular acoustic droplet vaporization in a single peritoneal macrophage for drug delivery applications. Langmuir 2011, 27:13183-13188.
37. Patil R.R., Guhagarkar S.A., Devarajan P.V. Engineered nanocarriers of doxorubicin: a current update. Crit Rev Ther Drug Carrier Syst 2008, 25:1-61.
38. Tinkov S., Winter G., Coester C., Bekeredjian R. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: part I - formulation development and in-vitro characterization. J Control Release 2010, 143:143-150.
39. Gaber M.H., Ghannam M.M., Ali S.A., Khalil W.A. Interaction of doxorubicin with phospholipid monolayer and liposomes. Biophys Chem 1998, 70:223-229.
40. Kheirolomoom A., Dayton P.A., Lum A.F., Little E., Paoli E.E., Zheng H., et al. Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J Control Release 2007, 118:275-284.
41. Caskey C.F., Qin S., Dayton P.A., Ferrara K.W. Microbubble tunneling in gel phantoms. J Acoust Soc Am 2009, 125:183-189.